111 related articles for article (PubMed ID: 27988892)
1. Immunolocalization of substance P and NK-1 receptor in vascular anomalies.
Ortiz-Prieto A; Bernabeu-Wittel J; Zulueta-Dorado T; Lorente-Lavirgen AI; Muñoz M
Arch Dermatol Res; 2017 Mar; 309(2):97-102. PubMed ID: 27988892
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of substance P and NK-1 receptor in Hofbauer cells in human normal placenta.
Muñoz M; Carranza A; Pavón A; Anderson G; Coveñas R
Microsc Res Tech; 2013 Dec; 76(12):1310-3. PubMed ID: 24155270
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of NK-1 receptor and Substance P in human normal placenta.
Muñoz M; Pavón A; Rosso M; Salinas MV; Pérez A; Carranza A; González-Ortega A
Placenta; 2010 Jul; 31(7):649-51. PubMed ID: 20430440
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
Muñoz M; Muñoz MF; Ayala A
J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
[TBL] [Abstract][Full Text] [Related]
5. Involvement of substance P and the NK-1 receptor in human pathology.
Muñoz M; Coveñas R
Amino Acids; 2014 Jul; 46(7):1727-50. PubMed ID: 24705689
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin-1 receptor: a new promising target in the treatment of cancer.
Muñoz M; Coveñas R
Discov Med; 2010 Oct; 10(53):305-13. PubMed ID: 21034671
[TBL] [Abstract][Full Text] [Related]
7. Substance P Regulation in Epilepsy.
Chi G; Huang Z; Li X; Zhang K; Li G
Curr Neuropharmacol; 2018; 16(1):43-50. PubMed ID: 28474564
[TBL] [Abstract][Full Text] [Related]
8. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
[TBL] [Abstract][Full Text] [Related]
9. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
10. The NK-1 receptor: a new target in cancer therapy.
Muñoz M; Rosso M; Coveñas R
Curr Drug Targets; 2011 Jun; 12(6):909-21. PubMed ID: 21226668
[TBL] [Abstract][Full Text] [Related]
11. Involvement of substance P and the NK-1 receptor in pancreatic cancer.
Muñoz M; Coveñas R
World J Gastroenterol; 2014 Mar; 20(9):2321-34. PubMed ID: 24605029
[TBL] [Abstract][Full Text] [Related]
12. Cancer progression and substance P.
Coveñas R; Muñoz M
Histol Histopathol; 2014 Jul; 29(7):881-90. PubMed ID: 24535838
[TBL] [Abstract][Full Text] [Related]
13. A new frontier in the treatment of cancer: NK-1 receptor antagonists.
Muñoz M; Rosso M; Coveñas R
Curr Med Chem; 2010; 17(6):504-16. PubMed ID: 20015033
[TBL] [Abstract][Full Text] [Related]
14. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist.
Gitter BD; Bruns RF; Howbert JJ; Waters DC; Threlkeld PG; Cox LM; Nixon JA; Lobb KL; Mason NR; Stengel PW
J Pharmacol Exp Ther; 1995 Nov; 275(2):737-44. PubMed ID: 7473161
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
19. Expression and localization of NK(1)R, substance P and CGRP are altered in dorsal root ganglia neurons of spontaneously hypertensive rats (SHR).
Aline Boer P; Ueno M; Sant'ana JS; Saad MJ; Gontijo JA
Brain Res Mol Brain Res; 2005 Jul; 138(1):35-44. PubMed ID: 15869822
[TBL] [Abstract][Full Text] [Related]
20. Wilms tumor 1 expression in vascular neoplasms and vascular malformations.
Trindade F; Tellechea O; Torrelo A; Requena L; Colmenero I
Am J Dermatopathol; 2011 Aug; 33(6):569-72. PubMed ID: 21697701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
